Manhattan Associates Reports First Quarter Results
RPO Increased 24% over Prior Year
“Manhattan is off to a strong start to 2026. On solid and broad-based demand, we accelerated our Q1 revenue growth and delivered better than expected bookings,” said
“While macro volatility persists, Manhattan’s fundamentals are solid. With a strong pipeline across our product suite, numerous opportunities to drive growth, and our unmatched ability to consistently deliver leading innovation to the supply chain commerce universe, we are optimistic about our long-term growth opportunity,”
FIRST QUARTER 2026 FINANCIAL SUMMARY:
-
Consolidated total revenue was
$282.2 million for Q1 2026, compared to$262.8 million for Q1 2025.-
Cloud subscription revenue was
$117.1 million for Q1 2026, compared to$94.3 million for Q1 2025. -
License revenue was
$2.2 million for Q1 2026, compared to$9.3 million for Q1 2025. -
Services revenue was
$125.7 million for Q1 2026, compared to$121.1 million for Q1 2025.
-
Cloud subscription revenue was
-
GAAP diluted earnings per share was
$0.82 for Q1 2026, compared to$0.85 for Q1 2025. -
Adjusted diluted earnings per share, a non-GAAP measure, was
$1.24 for Q1 2026, compared to$1.19 for Q1 2025. -
GAAP operating income was
$64.9 million for Q1 2026, compared to$63.2 million for Q1 2025. -
Adjusted operating income, a non-GAAP measure, was
$91.5 million for Q1 2026, compared to$91.3 million for Q1 2025. -
Cash flow from operations was
$84.0 million for Q1 2026, compared to$75.3 million for Q1 2025. Days Sales Outstanding was 72 days atMarch 31, 2026 , and 73 days atDecember 31, 2025 . -
Cash totaled
$226.1 million atMarch 31, 2026 , compared to$328.7 million atDecember 31, 2025 . -
RPO increased to
$2.35 billion as ofMarch 31, 2026 , compared to$2.23 billion as ofDecember 31, 2025 . -
During the three months ended
March 31, 2026 , the Company repurchased 1,043,312 shares ofManhattan Associates common stock under the share repurchase program authorized by our Board of Directors for a total investment of$150.0 million . InMarch 2026 , our Board of Directors approved an increase to the Company’s share repurchase authority from$100 million to$500 million . As of the end of the quarter, approximately$350.0 million remained under the existingMarch 2026 repurchase authority.
2026 GUIDANCE
|
|
|
||||||||||||
|
($'s in millions, except operating margin and EPS) |
$ Range |
|
% |
||||||||||
|
|
|
|
|
|
|
|
|
|
|||||
|
Total revenue |
|
|
|
|
|
|
6 |
% |
|
7 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
Operating Margin: |
|
|
|
|
|
|
|
|
||||
|
|
GAAP operating margin |
24.6 |
% |
|
24.9 |
% |
|
|
|
|
|
||
|
|
Equity-based compensation |
10.3 |
% |
|
10.2 |
% |
|
|
|
|
|
||
|
|
Adjusted operating margin(1) |
34.9 |
% |
|
35.1 |
% |
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
Diluted earnings per share (EPS): |
|
|
|
|
|
|
|
|
||||
|
|
GAAP EPS |
|
|
|
|
|
|
-1 |
% |
|
1 |
% |
|
|
|
Equity-based compensation |
1.70 |
|
|
1.70 |
|
|
|
|
|
|
||
|
|
Tax deficiency of stock awards vested (2) |
0.04 |
|
|
0.04 |
|
|
|
|
|
|
||
|
|
Adjusted EPS(1) |
|
|
|
|
|
|
5 |
% |
|
6 |
% |
|
|
|
|
|
|
||||||||||
|
|
(1) Adjusted operating margin and adjusted EPS are non-GAAP measures that exclude the impact of equity-based compensation, |
|
|||||||||||
|
|
expense related to an unusual health insurance claim, restructuring expense, and the related income tax effects, if applicable. |
||||||||||||
|
|
(2) The Company expects the tax deficiency on stock vesting to occur primarily in the first quarter of 2026. |
||||||||||||
|
|
|||||||||||||
CONFERENCE CALL
Manhattan Associates’ conference call regarding its first quarter financial results will be held today,
GAAP VERSUS NON-GAAP PRESENTATION
Non-GAAP adjusted operating income and margin, adjusted income tax provision, adjusted net income, and adjusted diluted earnings per share exclude the impact of equity-based compensation, an expense – net of insurance recoveries, related to an unusual health insurance claim, and restructuring expense – net of income tax effects, collectively. They also exclude the tax benefits or deficiencies of vested stock awards caused by differences in the amount deductible for tax purposes from the compensation expense recorded for financial reporting purposes. We include reconciliations of the Company’s GAAP financial measures to non-GAAP adjustments in the supplemental information attached to this release.
ABOUT
Our commitment to innovation, cloud-native platform and API-first architecture create simpler experiences and faster paths to value for our customers. We empower them to preempt and react to emerging trends and global disruptions with technical expertise and operational confidence, transforming challenges into competitive advantage. For more information, please visit www.manh.com.
This press release contains “forward-looking statements” relating to
|
Condensed Consolidated Statements of Income (in thousands, except per share amounts) |
||||
|
|
||||
|
|
|
Three Months Ended |
||
|
|
|
2026 |
|
2025 |
|
|
|
(unaudited) |
|
(unaudited) |
|
Revenue: |
|
|
|
|
|
Cloud subscriptions |
|
|
|
|
|
Software license |
|
2,234 |
|
9,292 |
|
Maintenance |
|
30,592 |
|
32,144 |
|
Services |
|
125,717 |
|
121,127 |
|
Hardware |
|
6,549 |
|
5,918 |
|
Total revenue |
|
282,215 |
|
262,787 |
|
Costs and expenses: |
|
|
|
|
|
Cost of cloud subscriptions, maintenance and services |
|
126,077 |
|
114,358 |
|
Cost of software license |
|
564 |
|
209 |
|
Research and development |
|
37,346 |
|
35,298 |
|
Sales and marketing |
|
27,752 |
|
21,061 |
|
General and administrative |
|
23,706 |
|
24,219 |
|
Depreciation and amortization |
|
1,833 |
|
1,541 |
|
Restructuring expense |
|
- |
|
2,929 |
|
Total costs and expenses |
|
217,278 |
|
199,615 |
|
Operating income |
|
64,937 |
|
63,172 |
|
Other income, net |
|
4,337 |
|
1,337 |
|
Income before income taxes |
|
69,274 |
|
64,509 |
|
Income tax provision |
|
19,979 |
|
11,927 |
|
Net income |
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per share |
|
|
|
|
|
Diluted earnings per share |
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of shares: |
|
|
|
|
|
Basic |
|
59,688 |
|
60,870 |
|
Diluted |
|
60,038 |
|
61,527 |
|
Reconciliation of Selected GAAP to Non-GAAP Measures (in thousands, except per share amounts) |
|||||||
|
|
|||||||
|
|
|
|
Three Months Ended |
||||
|
|
|
|
2026 |
|
|
2025 |
|
|
|
|
|
|
|
|
||
|
Operating income |
|
|
|
|
|
|
|
|
Equity-based compensation (a) |
|
|
26,524 |
|
|
28,826 |
|
|
Unusual health insurance claim (c) |
|
|
- |
|
|
(3,658 |
) |
|
Restructuring expense (d) |
|
|
- |
|
|
2,929 |
|
|
Adjusted operating income (Non-GAAP) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Income tax provision |
|
|
|
|
|
|
|
|
Equity-based compensation (a) |
|
|
3,698 |
|
|
4,340 |
|
|
Tax (deficiency) benefit of stock awards vested (b) |
|
|
(2,177 |
) |
|
3,542 |
|
|
Unusual health insurance claim (c) |
|
|
- |
|
|
(883 |
) |
|
Restructuring expense (d) |
|
|
- |
|
|
707 |
|
|
Adjusted income tax provision (Non-GAAP) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Net income |
|
|
|
|
|
|
|
|
Equity-based compensation (a) |
|
|
22,826 |
|
|
24,486 |
|
|
Tax deficiency (benefit) of stock awards vested (b) |
|
|
2,177 |
|
|
(3,542 |
) |
|
Unusual health insurance claim (c) |
|
|
- |
|
|
(2,775 |
) |
|
Restructuring expense (d) |
|
|
- |
|
|
2,222 |
|
|
Adjusted net income (Non-GAAP) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Diluted EPS |
|
|
|
|
|
|
|
|
Equity-based compensation (a) |
|
|
0.38 |
|
|
0.40 |
|
|
Tax deficiency (benefit) of stock awards vested (b) |
|
|
0.04 |
|
|
(0.06 |
) |
|
Unusual health insurance claim (c) |
|
|
- |
|
|
(0.05 |
) |
|
Restructuring expense (d) |
|
|
- |
|
|
0.04 |
|
|
Adjusted diluted EPS (Non-GAAP) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Fully diluted shares |
|
|
60,038 |
|
|
61,527 |
|
|
(a) |
Adjusted results exclude all equity-based compensation, as detailed below, to facilitate comparison with our peers and for the other reasons explained in our Current Report on Form 8-K filed with the |
|
|
|
|
Three Months Ended |
||
|
|
|
2026 |
2025 |
||
|
|
|
|
|
|
|
|
Cost of services |
|
|
|
|
|
|
Research and development |
|
|
6,387 |
|
5,958 |
|
Sales and marketing |
|
3,668 |
|
2,306 |
|
|
General and administrative |
|
4,883 |
|
9,137 |
|
|
Total equity-based compensation |
|
|
|
|
|
|
(b) |
Adjustments represent the excess tax benefits and tax deficiencies of the equity awards vested during the period. Excess tax benefits (deficiencies) occur when the amount deductible on our tax return for an equity award is more (less) than the cumulative compensation cost recognized for financial reporting purposes. As discussed above, we exclude equity-based compensation from adjusted non-GAAP results to be consistent with other companies in the software industry and for the other reasons explained in our Current Report on Form 8-K filed with the |
|
|
(c) |
In the fourth quarter of 2024, we recorded |
|
|
(d) |
In |
|
Condensed Consolidated Balance Sheets (in thousands, except share and per share data) |
||||||||
|
|
||||||||
|
|
|
|
|
|
|
|
||
|
|
|
(unaudited) |
|
|
|
|
||
|
ASSETS |
|
|
|
|
|
|
||
|
Current assets: |
|
|
|
|
|
|
||
|
Cash and cash equivalents |
|
$ |
226,133 |
|
|
$ |
328,747 |
|
|
Accounts receivable, net |
|
|
227,110 |
|
|
|
214,679 |
|
|
Prepaid expenses and other current assets |
|
|
62,573 |
|
|
|
39,912 |
|
|
Total current assets |
|
|
515,816 |
|
|
|
583,338 |
|
|
|
|
|
|
|
|
|
||
|
Property and equipment, net |
|
|
25,269 |
|
|
|
23,120 |
|
|
Operating lease right-of-use assets |
|
|
47,431 |
|
|
|
50,443 |
|
|
|
|
|
62,241 |
|
|
|
62,244 |
|
|
Deferred income taxes |
|
|
43,763 |
|
|
|
75,900 |
|
|
Other assets |
|
|
46,018 |
|
|
|
44,343 |
|
|
Total assets |
|
$ |
740,538 |
|
|
$ |
839,388 |
|
|
|
|
|
|
|
|
|
||
|
LIABILITIES AND SHAREHOLDERS' EQUITY |
|
|
|
|
|
|
||
|
Current liabilities: |
|
|
|
|
|
|
||
|
Accounts payable |
|
$ |
22,415 |
|
|
$ |
22,182 |
|
|
Accrued compensation and benefits |
|
|
58,415 |
|
|
|
69,309 |
|
|
Accrued and other liabilities |
|
|
30,571 |
|
|
|
26,570 |
|
|
Deferred revenue |
|
|
355,909 |
|
|
|
337,049 |
|
|
Income taxes payable |
|
|
90 |
|
|
|
803 |
|
|
Total current liabilities |
|
|
467,400 |
|
|
|
455,913 |
|
|
|
|
|
|
|
|
|
||
|
Operating lease liabilities, long-term |
|
|
55,685 |
|
|
|
56,180 |
|
|
Other non-current liabilities |
|
|
12,278 |
|
|
|
12,530 |
|
|
|
|
|
|
|
|
|
||
|
Shareholders' equity: |
|
|
|
|
|
|
||
|
Preferred stock, no par value; 20,000,000 shares authorized, no shares issued or outstanding in 2026 and 2025 |
|
|
- |
|
|
|
- |
|
|
Common stock, |
|
|
591 |
|
|
|
598 |
|
|
Retained earnings |
|
|
240,577 |
|
|
|
345,097 |
|
|
Accumulated other comprehensive loss |
|
|
(35,993 |
) |
|
|
(30,930 |
) |
|
Total shareholders' equity |
|
|
205,175 |
|
|
|
314,765 |
|
|
Total liabilities and shareholders' equity |
|
$ |
740,538 |
|
|
$ |
839,388 |
|
|
Condensed Consolidated Statements of Cash Flows (in thousands) |
||||||||
|
|
||||||||
|
|
|
Three Months Ended |
|
|||||
|
|
|
2026 |
|
|
2025 |
|
||
|
|
|
(unaudited) |
|
|
(unaudited) |
|
||
|
Operating activities: |
|
|
|
|
|
|
||
|
Net income |
|
$ |
49,295 |
|
|
$ |
52,582 |
|
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
||
|
Depreciation and amortization |
|
|
1,833 |
|
|
|
1,541 |
|
|
Equity-based compensation |
|
|
26,524 |
|
|
|
28,826 |
|
|
Gain on disposal of equipment |
|
|
(156 |
) |
|
|
(98 |
) |
|
Deferred income taxes |
|
|
31,854 |
|
|
|
2,133 |
|
|
Unrealized foreign currency (gain) loss |
|
|
(2,212 |
) |
|
|
781 |
|
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
||
|
Accounts receivable, net |
|
|
(13,217 |
) |
|
|
(3,321 |
) |
|
Other assets |
|
|
(9,651 |
) |
|
|
(11,959 |
) |
|
Accounts payable, accrued and other liabilities |
|
|
(4,044 |
) |
|
|
(18,807 |
) |
|
Income taxes |
|
|
(15,790 |
) |
|
|
6,482 |
|
|
Deferred revenue |
|
|
19,609 |
|
|
|
17,100 |
|
|
Net cash provided by operating activities |
|
|
84,045 |
|
|
|
75,260 |
|
|
|
|
|
|
|
|
|
||
|
Investing activities: |
|
|
|
|
|
|
||
|
Purchase of property and equipment |
|
|
(4,103 |
) |
|
|
(891 |
) |
|
Net cash used in investing activities |
|
|
(4,103 |
) |
|
|
(891 |
) |
|
|
|
|
|
|
|
|
||
|
Financing activities: |
|
|
|
|
|
|
||
|
Repurchase of common stock |
|
|
(179,387 |
) |
|
|
(136,447 |
) |
|
Net cash used in financing activities |
|
|
(179,387 |
) |
|
|
(136,447 |
) |
|
|
|
|
|
|
|
|
||
|
Foreign currency impact on cash |
|
|
(3,169 |
) |
|
|
1,721 |
|
|
|
|
|
|
|
|
|
||
|
Net change in cash and cash equivalents |
|
|
(102,614 |
) |
|
|
(60,357 |
) |
|
Cash and cash equivalents at beginning of period |
|
|
328,747 |
|
|
|
266,230 |
|
|
Cash and cash equivalents at end of period |
|
$ |
226,133 |
|
|
$ |
205,873 |
|
SUPPLEMENTAL INFORMATION
1. GAAP and adjusted earnings per share by quarter are as follows:
|
|
2025 |
|
|
|
|
|
2026 |
||||||||
|
|
1st Qtr |
|
2nd Qtr |
|
3rd Qtr |
|
4th Qtr |
|
Full Year |
|
1st Qtr |
||||
|
GAAP Diluted EPS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments to GAAP: |
|
|
|
|
|
|
|
|
|
|
|
||||
|
Equity-based compensation |
0.40 |
|
|
0.35 |
|
0.40 |
|
|
0.43 |
|
|
1.57 |
|
|
0.38 |
|
Tax deficiency (benefit) of stock awards vested |
(0.06 |
) |
|
- |
|
(0.01 |
) |
|
- |
|
|
(0.06 |
) |
|
0.04 |
|
Restructuring expense |
(0.05 |
) |
|
0.04 |
|
- |
|
|
(0.08 |
) |
|
(0.09 |
) |
|
- |
|
Unusual health insurance claim |
0.04 |
|
|
- |
|
- |
|
|
- |
|
|
0.04 |
|
|
- |
|
Adjusted Diluted EPS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fully Diluted Shares |
61,527 |
|
|
61,074 |
|
60,954 |
|
|
60,642 |
|
|
61,054 |
|
|
60,038 |
2. Revenues and operating income by reportable segment are as follows (in thousands):
|
|
2025 |
|
|
|
|
2026 |
||||||||
|
|
1st Qtr |
|
2nd Qtr |
|
3rd Qtr |
|
4th Qtr |
|
Full Year |
|
1st Qtr |
|||
|
Revenue: |
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EMEA |
55,542 |
|
|
52,301 |
|
53,975 |
|
53,978 |
|
|
215,796 |
|
|
53,663 |
|
APAC |
12,630 |
|
|
13,514 |
|
15,161 |
|
13,865 |
|
|
55,170 |
|
|
14,002 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
GAAP Operating Income: |
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EMEA |
23,703 |
|
|
19,807 |
|
22,877 |
|
21,686 |
|
|
88,073 |
|
|
19,670 |
|
APAC |
5,607 |
|
|
5,930 |
|
7,168 |
|
5,451 |
|
|
24,156 |
|
|
6,262 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Adjustments (pre-tax): |
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Equity-based compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unusual health insurance claim |
(3,658 |
) |
|
3,000 |
|
- |
|
(6,224 |
) |
|
(6,882 |
) |
|
- |
|
Restructuring expense |
2,929 |
|
|
8 |
|
- |
|
- |
|
|
2,937 |
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Adjusted non-GAAP Operating Income: |
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EMEA |
23,703 |
|
|
19,807 |
|
22,877 |
|
21,686 |
|
|
88,073 |
|
|
19,670 |
|
APAC |
5,607 |
|
|
5,930 |
|
7,168 |
|
5,451 |
|
|
24,156 |
|
|
6,262 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3. Impact of Currency Fluctuation
The following table reflects the increases (decreases) in the results of operations for each period attributable to the change in foreign currency exchange rates from the prior period as well as foreign currency gains (losses) included in other income, net for each period (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
2025 |
|
|
|
2026 |
||||||||
|
|
1st Qtr |
|
2nd Qtr |
|
3rd Qtr |
|
4th Qtr |
|
Full Year |
|
1st Qtr |
||
|
Revenue |
$(1,591 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Costs and expenses |
(1,966 |
) |
|
1,180 |
|
|
738 |
|
906 |
|
858 |
|
2,646 |
|
Operating income |
375 |
|
|
1,544 |
|
|
1,914 |
|
2,927 |
|
6,760 |
|
3,329 |
|
Foreign currency gains (losses) in other income |
131 |
|
|
(65 |
) |
|
1,596 |
|
9 |
|
1,671 |
|
3,229 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2025 |
|
2026 |
||||||||
|
|
1st Qtr |
|
2nd Qtr |
|
3rd Qtr |
|
4th Qtr |
|
Full Year |
|
1st Qtr |
|
Operating income |
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency gains (losses) in other income |
15 |
|
140 |
|
1,978 |
|
742 |
|
2,875 |
|
3,449 |
|
Total impact of changes in the Indian Rupee |
|
|
|
|
|
|
|
|
|
|
|
4. Other income includes the following components (in thousands):
|
|
2025 |
|
|
|
2026 |
||||||||
|
|
1st Qtr |
|
2nd Qtr |
|
3rd Qtr |
|
4th Qtr |
|
Full Year |
|
1st Qtr |
||
|
Interest income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency gains (losses) |
130 |
|
(65 |
) |
|
1,597 |
|
9 |
|
|
1,671 |
|
3,229 |
|
Other non-operating income (expense) |
106 |
|
(72 |
) |
|
- |
|
(1 |
) |
|
33 |
|
157 |
|
Total other income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
5. Capital expenditures are as follows (in thousands):
|
|
2025 |
|
2026 |
||||||||
|
|
1st Qtr |
|
2nd Qtr |
|
3rd Qtr |
|
4th Qtr |
|
Full Year |
|
1st Qtr |
|
Capital expenditures |
|
|
|
|
|
|
|
|
|
|
|
6. Stock Repurchase Activity (in thousands):
|
|
2025 |
|
2026 |
||||||||
|
|
1st Qtr |
|
2nd Qtr |
|
3rd Qtr |
|
4th Qtr |
|
Full Year |
|
1st Qtr |
|
Shares purchased under publicly-announced buy-back program |
539 |
|
263 |
|
233 |
|
416 |
|
1,451 |
|
1,043 |
|
Shares withheld for taxes due upon vesting of restricted stock |
179 |
|
3 |
|
8 |
|
2 |
|
192 |
|
198 |
|
Total shares purchased |
718 |
|
266 |
|
241 |
|
418 |
|
1,643 |
|
1,241 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total cash paid for shares purchased under publicly-announced buy-back program |
|
|
|
|
|
|
|
|
|
|
|
|
Total cash paid for shares withheld for taxes due upon vesting of restricted stock |
36,447 |
|
595 |
|
1,602 |
|
398 |
|
39,042 |
|
29,404 |
|
Total cash paid for excise tax |
- |
|
- |
|
- |
|
1,581 |
|
1,581 |
|
- |
|
Total cash paid for shares repurchased |
|
|
|
|
|
|
|
|
|
|
|
7. Remaining Performance Obligations
We disclose revenue that we expect to recognize from our remaining performance obligations ("RPO"). Over 98% of our RPO represents cloud native subscriptions with non-cancelable terms greater than one year (including cloud-deferred revenue as well as amounts we will invoice and recognize as revenue from our performance of cloud services in future periods). Maintenance contracts are typically one year and not included in the RPO. Our RPO as of the end of each period appears below (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
Remaining Performance Obligations |
|
|
|
|
|
|
|
|
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20260421438075/en/
VP, Investor Relations
678-597-7538
mbauer@manh.com
Director, Corporate Communications
678-597-6754
dgoel@manh.com
Source: